Recombinant ADA2 Monoclonal Antibody

• Background:

  ADA2, also named as TADA2A, is a subunit of the ADA2A-containing (ATAC) histone acetyltransferase complex, which with histone acetyltransferase activity on histones H3 and H4. It is required for the function of some acidic activation domains, which activate transcription from a distant site. It has a role in chromatin remodeling by binding at the linker region between neighbouring unclesomes of dinucleosomes.

• Abbreviation:

  ADA2

• UniProt:

  Q9NZK5

• Host:

  Rabbit

• Reactivity:

  Human

• Immunogen:

  Peptide. This information is proprietary to PTMab.

• Target:

  ADA; Cat eye syndrome critical region protein; Cat eye syndrome chromosome region candidate; PAN; ADGF; CECR1; IDGFL; SNEDS; VAIHS; Cat eye syndrome chromosome region candidate 1; Cat eye syndrome critical region protein 1; Cat eye syndrome critical region protein 1 precursor; CECR 1; ADA2; ADGF; CECR1; IDGFL; SNEDS; VAIHS

• Clonality:

  Monoclonal, Recombinant

• Clone:

  A727

• Conjugation:

  Unconjugated

• Applications:

  WB; IHC

• Field of Research:

  Epigenetics and Nuclear Signaling

• Purification:

  Protein A purified

• Concentration:

  1 mg/mL

• Dilution:

  WB 1:1000; IHC 1:1000-1:2000

• Buffer:

  PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.

• Shipping Conditions:

  Ice bag

• Storage Conditions:

  Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

• Calculated Molecular Weight:

  59 kDa

• Observed Molecular Weight:

  65 kDa

• Isotype:

  IgG, κ